Is it a good company at a reasonable price? Analysts’ recommendations are all over the place from Strong Buy to Sell. Analyst 12 months stock price is lower than the current stock price. You have to wonder if this will be a profitable company again. I am not interested in this at present. It would seem to be have a rather high price at this point.
I do not own this stock of BlackBerry Ltd (TSX-BB, NYSE-BB) but I used to. I bought this stock for capital gain. I first bought it in 1999 and then some more in 2000. I sold some in 2006 and 2007 to lock in some profit. I sold the rest of my stock in 2010. I had this stock for just over 10 years and a total return of 20.18% per year.
When I was updating my spreadsheet, I noticed that the stock price has climbed a lot recently and the stock price is up 132% to July 25, 2026. In this case if you had invested in this company in December 2016, for $1,000.62 you would have bought 109 shares at $9.18 per share. On July 25, 2026, after almost 10 years you would have received $0 in dividends. The stock would be worth $1,312.36. Your total return would have been $1,312.36. This would be a total return of 2.75% per year with 2.75% from capital gain and 0% from dividends. The total return for the last 5 years from December 2015 to December 2025 is less. See chart of total return below. There has not been a positive 5 year total return for quite some time. (Note that in August 2026, stock price has comedown a bit and 5 year total return is now on 2.65%)
| Cost | Tot. Cost | Shares | Years | Dividends | Stock Val | Tot Ret |
|---|---|---|---|---|---|---|
| $9.18 | $1,000.62 | 109 | 10 | $0.00 | $1,312.36 | $1,312.36 |
I also noticed that all the officers I follow have bought more shares over the past years. None of the directors have and most of the directors, including the chairman have no shares at all. They all have Deferred Share Units. The last thing to mention is that analysts are all over place on their recommendations from Strong Buy to Sell.
Please note that the financial year for this stock ends at February 28 each year. I am looking at the February 28, 2026 fourth quarter financial results. The estimates are for the financial year ending in February 28, 2027. The financial statements and the estimates I found are all in US$.
This stock never paid a dividend so there is no dividend yield or Dividend Payout Ratios (DPR).
Debt Ratios are good. The Long Term Debt/Market Cap Ratio for 2025 is good at 0.10 and currently at 0.04. The Liquidity Ratio for 2025 is good at 2.12 and 2.10 currently. The Debt Ratio for 2025 is good at 2.49 and 2.49 currently. The Leverage and Debt/Equity Ratios for 2025 are good at 1.67 and 0.67 and currently at 1.67 and 0.67.
| Type | Year End | Ratio Curr |
|---|---|---|
| Lg Term R | 0.10 | 0.04 |
| Intang/GW | 0.81 | 0.32 |
| Liquidity | 2.12 | 2.10 |
| Liq. + CF | 2.27 | 2.27 |
| Debt Ratio | 2.49 | 2.49 |
| Leverage | 1.67 | 1.67 |
| D/E Ratio | 0.67 | 0.67 |
The Total Return per Year is shown below for years of 5 to 29 to the end of 2025 in CDN$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.
| From | Years | Div. Gth | Tot Ret | Cap Gain | Div. |
|---|---|---|---|---|---|
| 2020 | 5 | 0.00% | -9.30% | -9.30% | 0.00% |
| 2015 | 10 | 0.00% | -8.68% | -8.68% | 0.00% |
| 2010 | 15 | 0.00% | -14.88% | -14.88% | 0.00% |
| 2005 | 20 | 0.00% | -7.67% | -7.67% | 0.00% |
| 2000 | 25 | 0.00% | -5.28% | -5.28% | 0.00% |
| 1996 | 29 | 0.00% | 5.15% | 5.15% | 0.00% |
The Total Return per Year is shown below for years of 5 to 29 to the end of 2025 in US$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.
| From | Years | Div. Gth | Tot Ret | Cap Gain | Div. |
|---|---|---|---|---|---|
| 2020 | 5 | 0.00% | -10.58% | -10.58% | 0.00% |
| 2015 | 10 | 0.00% | -8.57% | -8.57% | 0.00% |
| 2010 | 15 | 0.00% | -16.64% | -16.64% | 0.00% |
| 2005 | 20 | 0.00% | -8.42% | -8.42% | 0.00% |
| 2000 | 25 | 0.00% | -4.91% | -4.91% | 0.00% |
| 1996 | 29 | 0.00% | 5.15% | 5.15% | 0.00% |
The 5-year low, median, and high median Price/Earnings per Share Ratios are negative and useless. The corresponding 10 year ratios are negative and useless. The corresponding historical ratio are 6.62, 11.95 and 15.48. The current ratio is 74.61 based on a stock price of $8.58 and EPS estimate for 2027 of $0.12. The current ratio is very high and would imply that the stock price is relatively expensive. This testing is in US$.
I also have Adjusted Earnings per Share (AEPS) data. The 5-year low, median, and high median Price/Adjusted Earnings per Share Ratios are 17.94, 23.16 and 28.38. The corresponding 10 year ratios are 39.84, 82.65 and 115.53. The corresponding historical ratio are 8.18, 17.25 and 28.38. The current ratio is 45.16 based on a stock price of $8.58 and AEPS estimate for 2027 of $0.19. The current ratio is between the low and median ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median. This testing is in US$. These ratios are also very high.
I get a Graham Price of $3.24. The 10-year low, median, and high median Price/Graham Price Ratios are 1.98, 3.43 and 4.33. The current ratio is 3.69 based on a stock price of $11.93. The current ratio is between the median and high ratios of the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable but above the median. This testing is in CDN$.
I get a 10-year median Price/Book Value per Share Ratio of 2.73. The current ratio is 6.95 based on Book Value of $725M, Book Value per Share of $1.23 and a stock price of $8.58. The current ratio is 154% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive. This testing is in US$.
I get a 10-year median Price/Cash Flow per Share Ratio of 7.91. The current ratio is 122.57 based on Cash Flow per Share estimate for 2027 of $0.07, Cash Flow of $41.1M and a stock price of $8.58. The current ratio is 1450% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive. This testing is in US$.
I cannot do any dividend yield testing as this stock does not have a dividend.
The 10-year median Price/Sales (Revenue) Ratio is 4.27. The current ratio is 8.20 based on Revenue estimate for 2027 of $614.5M, Revenue per Share of $1.05 and a stock price of $8.58. The current ratio is 92% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive. This testing is in US$.
Results of stock price testing is that the stock price is probably expensive. The P/S Ratio test is saying this. Another usually good test is the P/GP Ratio test that is saying that the stock price is reasonable but above the median. However, the P/GP Ratio are very high. A number of tests are saying that the stock price is relatively high.
When I look at analysts’ recommendations, I find Strong Buy (1), Buy (1), Hold (4), Underperform (1) and Sell (1). The consensus would be a Hold. The 12 month stock price consensus is $11.43 ($8.11 US$) with a High of $16.91 ($12.00 US$) and low of $7.44 ($5.28 US$). The 12 month consensus stock price of $11.43 implies a total loss of 4.20% based on a current stock price of $11.93.
There seems to be as many analysts on Stock Chase calling for a Sell as calling for a Buy. One analyst says that its overriding challenge is that it's a fallen champion. Stock Chase gives this stock 2 and one half stars out of 5. Karen Thomas on Motley Fool thinks that this stock is worth buying and holding for the Long Term. Christopher Liew on Motley Fool says it is now a software-growth story suited to investors seeking growth despite market turbulence. The company put out a Press Release about their fourth quarter ending in February 2026. The company put out a Press Release about their first quarter of 2027 ending in May 2026.
Zacks via Yahoo Finance reviews this stock. Vaishali Doshi says it started strong in fiscal year 2027, but can it deliver. Simply Wall Street via Yahoo Finance reviews this stock. They think it might be overvalued. They say some think it is undervalued and some think it is overvalued. They have one warning of Significant insider selling over the past 3 months. But that is options not taken up. All the officers I am following bought shares in the past year. However, I can only find one director with any shares. Mostly the directors have options.
BlackBerry, once known for being the world's largest smartphone manufacturer, is now exclusively a software provider with a stated goal of end-to-end secure communications for enterprises. Its web site is here BlackBerry Ltd.
The last stock I wrote about was about was Well Health Technologies Corp (TSX-WELL, OTCQX-WHTCF) ... learn more. The next stock I will write about will be Andrew Peller Ltd (TSX-ADW.A, OTC-ADWPF) ... learn more on Wednesday, August 5, 2026 around 5 pm. Tomorrow on my other blog I will write about Dividend Stocks August 2026.... learn more on Tuesday, June 30, 2026 around 5 pm.
This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.
See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.
